0001646626-15-000004.txt : 20150708 0001646626-15-000004.hdr.sgml : 20150708 20150708171027 ACCESSION NUMBER: 0001646626-15-000004 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150701 FILED AS OF DATE: 20150708 DATE AS OF CHANGE: 20150708 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chawla Lakhmir S CENTRAL INDEX KEY: 0001646626 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 15979814 MAIL ADDRESS: STREET 1: 1960 KIRBY ROAD CITY: MCLEAN STATE: VA ZIP: 22101 3 1 wf-form3_143638981749746.xml FORM 3 X0206 3 2015-07-01 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001646626 Chawla Lakhmir S C/O LA JOLLA PHARMACEUTICAL COMPANY, 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 17.34 2025-02-06 Common Stock 60000.0 D Represents an option to purchase a total of 60,000 shares of the Issuer's Common Stock previously issued pursuant to a consultancy arrangement. The option was fully vested with respect to one quarter of the underlying shares on the date of grant, with the remaining shares vesting quarterly thereafter over the next three years. /s/ Chester S. Zygmont, III as attorney-in-fact for Lakhmir S. Chawla 2015-07-08